A phase I study of intermittent infusion cladribine in patients with solid tumors
- 1 July 1994
- Vol. 74 (1) , 168-173
- https://doi.org/10.1002/1097-0142(19940701)74:1<168::aid-cncr2820740127>3.0.co;2-t
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- 2-Chlorodeoxyadenosine dose escalation in nonhematologic malignancies.Journal of Clinical Oncology, 1993
- Treatment of Waldenstrom Macroglobulinemia with 2-ChlorodeoxyadenosineAnnals of Internal Medicine, 1993
- A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemiaBlood, 1992
- Response to 2-Chlorodeoxyadenosine in Patients with B-Cell Chronic Lymphocytic Leukemia Resistant to FludarabineNew England Journal of Medicine, 1992
- 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T- cell lymphomaBlood, 1992
- Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA)Blood, 1992
- A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia.Journal of Clinical Oncology, 1991
- Lasting Remissions in Hairy-Cell Leukemia Induced by a Single Infusion of 2-ChlorodeoxyadenosineNew England Journal of Medicine, 1990
- 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemiaBlood, 1988
- Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo.Proceedings of the National Academy of Sciences, 1980